8-KThe WireRoutine
Reg FD Disclosure
Filed Mar 2, 2026 · 4mo ago · Accession 0001193125-26-084266
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- NewAmsterdam Pharma Co N.V.
- Ticker
- NAMS
- CIK
- 1936258
- Form type
- 8-K
- Filing date
- Mar 2, 2026
- Report date
- Mar 2, 2026
- Document
- nams-20260302.htm
- Size
- 17.7 MB